Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Na minha lista:

Detalhes bibliográficos
Publicado no:	Journal for Immunotherapy of Cancer vol. 13, no. 2 (Feb 2025), p. e009352
Autor principal:	Eigentler, Thomas
Outros Autores:	Thomas, Ioannis, Samoylenko, Igor, Erdmann, Michael, Heinzerling, Lucie, Ochsenreither, Sebastian, Krauss, Jürgen, Oberoi, Arjun, Robert, Caroline, Lebbe, Celeste, Martin-Liberal, Juan, Koch, Lukas, Richtig, Erika, Terheyden, Patrick, Weishaupt, Carsten, Mohr, Peter, Semiletova, Yulia, Casilda Llacer Perez, Brossart, Peter, Bauernfeind, Franz Georg, Fluck, Michael, Poltoratskiy, Artem, Sekacheva, Marina, Soria, Ainara, Schmitt-Bormann, Beate, Gonzalez, Marina, Heß, Jana, Wengenmayer, Peter, Seibel, Tobias, Koch, Sven D, Quintini, Gianluca, Codó, Paula, Falk, Martin, Schönborn-Kellenberger, Oliver, Gnad-Vogt, Ulrike
Publicado em:	BMJ Publishing Group LTD
Assuntos:	Head & neck cancer Biomarkers Squamous cell carcinoma Vaccines Cell death Metastasis Melanoma Peptides Tumors Cancer therapies Immunology Proteins Skin cancer
Acesso em linha:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Seja o primeiro a partilhar um comentário!